scholarly journals Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer

2017 ◽  
Vol 14 (3) ◽  
pp. 777-804 ◽  
Author(s):  
Alacia M. Voth ◽  
◽  
John G. Alford ◽  
Edward W. Swim ◽  
Keyword(s):  
Mathematical Modeling ◽  
Prostate Cancer ◽  
Advanced Prostate Cancer ◽  
Intermittent Androgen Suppression ◽  
Androgen Suppression

INTERMITTENT ANDROGEN SUPPRESSION IN PATIENTS WITH ADVANCED PROSTATE CANCER: AN UPDATE OF THE TULP SURVIVAL DATA

2008 ◽  
Vol 7 (3) ◽  
pp. 205 ◽  
Author(s):  
J.F. Langenhuijsen ◽  
E.M.C. Schasfoort ◽  
P. Heathcote ◽  
M.T.W.T. Lock ◽  
M. Zerbib ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Survival Data ◽  
Advanced Prostate Cancer ◽  
Intermittent Androgen Suppression ◽  
Androgen Suppression

scholarly journals Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression

2012 ◽  
Vol 4 (3) ◽  
pp. 127-132 ◽  
Author(s):  
Yoshito Hirata ◽  
Koichiro Akakura ◽  
Celestia S. Higano ◽  
Nicholas Bruchovsky ◽  
Kazuyuki Aihara
Keyword(s):  
Mathematical Modeling ◽  
Prostate Cancer ◽  
Cancer Patients ◽  
Intermittent Androgen Suppression ◽  
Androgen Suppression

scholarly journals Case: Testicular oligometastasis from prostate cancer — Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy

2017 ◽  
Vol 12 (1) ◽  
pp. E31-3 ◽  
Author(s):  
Chan-Kyung J. Cho ◽  
Samantha Sigurdson ◽  
Christopher M. Davidson ◽  
Michael Leveridge ◽  
Aamer Mahmud
Keyword(s):  
Prostate Cancer ◽  
Androgen Deprivation Therapy ◽  
Advanced Prostate Cancer ◽  
External Beam Radiotherapy ◽  
Locally Advanced ◽  
Androgen Deprivation ◽  
High Dose ◽  
Locally Advanced Prostate Cancer ◽  
Intermittent Androgen Suppression ◽  
Androgen Suppression

Testicular oligometastasis secondary to prostate cancer is rare. We present a case where a patient with locally advanced prostate cancer was treated with high-dose external beam radiotherapy and two years of androgen-deprivation therapy, followed by intermittent androgen suppression. Three and a half years after initial diagnosis, he was found to have a painless testicular mass. Orchiectomy was performed and histopathology demonstrated metastatic prostatic adenocarcinoma. He remains in clinical remission on intermittent androgen suppression eight years following initial treatment, and over four years after presentation with testicular metastasis.

Sign in / Sign up

Export Citation Format

Share Document